JP7346712B2 - ベタメタゾン吉草酸エステル含有医薬組成物 - Google Patents

ベタメタゾン吉草酸エステル含有医薬組成物 Download PDF

Info

Publication number
JP7346712B2
JP7346712B2 JP2022508438A JP2022508438A JP7346712B2 JP 7346712 B2 JP7346712 B2 JP 7346712B2 JP 2022508438 A JP2022508438 A JP 2022508438A JP 2022508438 A JP2022508438 A JP 2022508438A JP 7346712 B2 JP7346712 B2 JP 7346712B2
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
component
composition containing
allantoin
stability
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022508438A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021187592A1 (https=
JPWO2021187592A5 (https=
Inventor
博志 村里
宜孝 友田
文枝 純浦
洋一 岩田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHIONOGI HEALTHCARE CO., LTD.
Original Assignee
SHIONOGI HEALTHCARE CO., LTD.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHIONOGI HEALTHCARE CO., LTD. filed Critical SHIONOGI HEALTHCARE CO., LTD.
Publication of JPWO2021187592A1 publication Critical patent/JPWO2021187592A1/ja
Publication of JPWO2021187592A5 publication Critical patent/JPWO2021187592A5/ja
Application granted granted Critical
Publication of JP7346712B2 publication Critical patent/JP7346712B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2022508438A 2020-03-18 2021-03-18 ベタメタゾン吉草酸エステル含有医薬組成物 Active JP7346712B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2020047638 2020-03-18
JP2020047638 2020-03-18
PCT/JP2021/011175 WO2021187592A1 (ja) 2020-03-18 2021-03-18 ベタメタゾン吉草酸エステル含有医薬組成物

Publications (3)

Publication Number Publication Date
JPWO2021187592A1 JPWO2021187592A1 (https=) 2021-09-23
JPWO2021187592A5 JPWO2021187592A5 (https=) 2023-06-28
JP7346712B2 true JP7346712B2 (ja) 2023-09-19

Family

ID=77772186

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022508438A Active JP7346712B2 (ja) 2020-03-18 2021-03-18 ベタメタゾン吉草酸エステル含有医薬組成物

Country Status (3)

Country Link
JP (1) JP7346712B2 (https=)
TW (1) TWI867191B (https=)
WO (1) WO2021187592A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023007359A (ja) * 2021-06-29 2023-01-18 ロート製薬株式会社 皮膚外用医薬組成物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005343891A (ja) 2004-05-07 2005-12-15 Rohto Pharmaceut Co Ltd 皮膚外用剤
JP2005343890A (ja) 2004-05-07 2005-12-15 Rohto Pharmaceut Co Ltd 皮膚外用剤
JP2006036675A (ja) 2004-07-26 2006-02-09 Zeria Pharmaceut Co Ltd 外用剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3434911B2 (ja) * 1994-09-29 2003-08-11 日清ファルマ株式会社 皮膚外用剤
JP2005343834A (ja) * 2004-06-03 2005-12-15 Rohto Pharmaceut Co Ltd 皮膚外用剤
US9861645B2 (en) * 2012-12-28 2018-01-09 Rak Holdings Llc Anti-itch scalp treatment compositions and combinations

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005343891A (ja) 2004-05-07 2005-12-15 Rohto Pharmaceut Co Ltd 皮膚外用剤
JP2005343890A (ja) 2004-05-07 2005-12-15 Rohto Pharmaceut Co Ltd 皮膚外用剤
JP2006036675A (ja) 2004-07-26 2006-02-09 Zeria Pharmaceut Co Ltd 外用剤

Also Published As

Publication number Publication date
JPWO2021187592A1 (https=) 2021-09-23
TWI867191B (zh) 2024-12-21
TW202200154A (zh) 2022-01-01
WO2021187592A1 (ja) 2021-09-23

Similar Documents

Publication Publication Date Title
AU2015229243B2 (en) Formulation for soft anticholinergic analogs
US20100166886A1 (en) Methods of treating the skin
AU2009223158B2 (en) Formulations of vitamin K analogs for topical use
CN105050584A (zh) 具有提高的生物利用度的皮质类固醇的局部制剂
EP3927319A1 (en) Topical rapamycin formulations and their use in treating facial angiofibromas and other skin disorders
JP7664689B2 (ja) 外用組成物
EP2663299A1 (en) Melatonin and an antimicrobial or antibacterial agent for the treatment of acne
JP7346712B2 (ja) ベタメタゾン吉草酸エステル含有医薬組成物
AU2003294027B2 (en) Pharmaceutical compositions comprising a combination of calcitriol and a clobetasol propionate
JP2023044680A (ja) ベタメタゾン吉草酸エステル及びジフェンヒドラミン含有医薬組成物
RU2325912C1 (ru) Фармацевтическая композиция противовоспалительного и антимикробного действия в форме мази на гидрофобной основе для лечения кожных заболеваний (варианты)
ZA200505174B (en) Pharmaceutical compositions comprising a combination of calcitriol and a clobetasol propionate
JP7361448B2 (ja) トランスグルタミナーゼ発現促進剤
TWI885097B (zh) 含戊酸倍他米松(betamethasone valerate)之組成物
JP2023044681A (ja) ベタメタゾン吉草酸エステル含有軟膏剤
US12343374B2 (en) Enhancement of antibacterial actions of a depsipeptide antibiotic using synergistic amounts of boric acid
JP7309215B2 (ja) 皮膚外用剤
JP2023044682A (ja) ベタメタゾン吉草酸エステル含有クリーム剤
US8192750B2 (en) Pharmaceutical composition for the treatment of otomycosis
KR20180135169A (ko) 퀘르세틴 및 비타민 d를 함유하는 여드름 피부 개선용 조성물
JP2024122448A (ja) 外用医薬組成物
AU2011242139B2 (en) Compositions containing anti-acne agents and the use thereof
HK40119928A (en) Ruxolitinib composition and preparation method therefor
EP1854466A1 (en) Pharmaceutical composition comprising a combination of calcitriol and clobetasol propionate
JP7214331B2 (ja) 医薬組成物

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230614

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20230614

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230619

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20230711

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230726

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230808

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230906

R150 Certificate of patent or registration of utility model

Ref document number: 7346712

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350